Dr. Jonathan Emberson

Biography

Jonathan Emberson is a Professor of Medical Statistics within the Medical Sciences Division at the University of Oxford. He is a Principal Investigator in the Mexico City Prospective Study, directing research that focuses on the causes and prevention of cardiovascular diseases. His work involves the design, conduct, analysis, and interpretation of large-scale observational cohort studies and randomized controlled trials. Notably, his contributions to meta-analyses have influenced global practices regarding the use of aspirin, statins, and blood pressure-lowering medications in the prevention of cardiovascular diseases. His involvement in the RECOVERY trial significantly impacted the treatment of COVID-19, demonstrating that dexamethasone substantially reduced mortality in severely ill patients. Since 2013, Jonathan has been a UK Principal Investigator in the Mexico City Prospective Study, investigating both genetic and non-genetic contributors to premature morbidity and mortality among 150,000 Mexican adults. Prior to joining the Clinical Trials Service Unit in 2004, Jonathan completed his undergraduate degree in Mathematics and an MSc in Applied Statistics at the University of Oxford, followed by a PhD in Epidemiology from University College London. He has also worked in clinical trials at the University of Sydney and has supervised numerous students at the MSc and DPhil levels.

Research Interests

Experience